AURA Takes you to the home page

Aberdeen University Research Archive >
6 - All research >
All research >

Please use this identifier to cite or link to this item:

This item has been viewed 5 times in the last year. View Statistics

Files in This Item:

File Description SizeFormat
Hernandez 2007.pdf290.38 kBAdobe PDFView/Open
Title: The value of myocardial perfusion scintigraphy in the diagnosis and management of angina and myocardial infarction : a probabilistic analysis
Authors: Hernández, Rodolfo Andrés
Vale, Luke David
University of Aberdeen, School of Medicine & Dentistry, Division of Applied Health Sciences
Keywords: : coronary heart disease
coronary artery disease
cost-utility analyses
probabilistic sensitivity analysis
Issue Date: 7-Nov-2007
Publisher: Sage
Citation: Hernandez, R., and Vale, L. (2007). The value of myocardial perfusion scintigraphy in the diagnosis and management of angina and myocardial infarction : a probabilistic analysis. Medical Decision Making, 27(6), pp. 772-788.
Abstract: Background and Aim. Coronary heart disease (CHD) is the most common cause of death in the United Kingdom, accounting for more than 120,000 deaths in 2001, among the highest rates in the world. This study reports an economic evaluation of single photon emission computed tomography myocardial perfusion scintigraphy (SPECT) for the diagnosis and management of coronary artery disease (CAD). Methods. Strategies involving SPECT with and without stress electrocardiography (ECG) and coronary angiography (CA) were compared to diagnostic strategies not involving SPECT. The diagnosis decision was modelled with a decision tree model and long-term costs and consequences using a Markov model. Data to populate the models were obtained from a series of systematic reviews. Unlike earlier evaluations, a probabilistic analysis was included to assess the statistical imprecision of the results. The results are presented in terms of incremental cost per quality-adjusted life year (QALY). Results. At prevalence levels of CAD of 10.5%, SPECT-based strategies are costeffective; ECG-CA is highly unlikely to be optimal. At a ceiling ratio of _20,000 per QALY, SPECT-CA has a 90% likelihood of being optimal. Beyond this threshold, this strategy becomes less likely to be cost-effective. At more than _75,000 per QALY, coronary angiography is most likely to be optimal. For higher levels of prevalence (around 50%) and more than a _10,000 per QALY threshold, coronary angiography is the optimal decision. Conclusions. SPECTbased strategies are likely to be cost-effective when risk of CAD is modest (10.5%). Sensitivity analyses show these strategies dominated non-SPECT-based strategies for risk of CAD up to 4%. At higher levels of prevalence, invasive strategies may become worthwhile. Finally, sensitivity analyses show stress echocardiography as a potentially costeffective option, and further research to assess the relative cost-effectiveness of echocardiography should also be performed.
ISSN: 0272-989X
Appears in Collections:Applied Health Sciences research
All research

SFX Query

Items in AURA are protected by copyright, with all rights reserved, unless otherwise indicated.


The University of Aberdeen
King's College
AB24 3FX
Tel: +44 (0)1224-272000